Effectiveness of Anti-Dementia Drugs in Extremely Severe Alzheimer’s Disease: A 12-Week, Multicenter, Randomized, Single-Blind Study
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effectiveness of Anti-Dementia Drugs in Extremely Severe Alzheimer’s Disease: A 12-Week, Multicenter, Randomized, Single-Blind Study
Authors
Keywords
-
Journal
JOURNAL OF ALZHEIMERS DISEASE
Volume 63, Issue 3, Pages 1035-1044
Publisher
IOS Press
Online
2018-04-29
DOI
10.3233/jad-180159
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional Assessment Staging (FAST) in Korean Patients with Alzheimer's Disease
- (2017) Hae-Ri Na et al. JOURNAL OF ALZHEIMERS DISEASE
- Longitudinal course of behavioural and psychological symptoms of dementia: systematic review
- (2016) Rianne M. van der Linde et al. BRITISH JOURNAL OF PSYCHIATRY
- Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial)
- (2016) Martin Knapp et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Cognitive Efficacy (SIB) of 13.3 Versus 4.6 mg/24 h Rivastigmine Patch in Severe Alzheimer’s Disease
- (2015) Richard S. Isaacson et al. American Journal of Alzheimers Disease and Other Dementias
- Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses
- (2015) Robert Howard et al. LANCET NEUROLOGY
- Withdrawal syndrome after donepezil cessation in a patient with dementia
- (2012) Leszek Bidzan et al. NEUROLOGICAL SCIENCES
- Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
- (2012) Robert Howard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study
- (2010) Martin R. Farlow et al. CLINICAL THERAPEUTICS
- Discontinuing cholinesterase inhibitors: results of a survey of Canadian dementia experts
- (2010) Nathan Herrmann et al. INTERNATIONAL PSYCHOGERIATRICS
- Understanding Equivalence and Noninferiority Testing
- (2010) Esteban Walker et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Trajectories of Disability in the Last Year of Life
- (2010) Thomas M. Gill et al. NEW ENGLAND JOURNAL OF MEDICINE
- Korean Version of the Baylor Profound Mental Status Examination: A Brief Staging Measure for Patients with Severe Alzheimer’s Disease
- (2009) H.R. Na et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Two cases of discontinuation syndrome following cessation of memantine
- (2009) Yong Tae Kwak et al. Geriatrics & Gerontology International
- Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease
- (2009) Susan D Rountree et al. Alzheimers Research & Therapy
- Behavioral effects of current Alzheimer’s disease treatments: A descriptive review
- (2008) Jeffrey L. Cummings et al. Alzheimers & Dementia
- Integrating Palliative Medicine into the Care of Persons with Advanced Dementia: Identifying Appropriate Medication Use
- (2008) Holly M. Holmes et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- An adaptation of the Korean mini-mental state examination (K-MMSE) in elderly Koreans: Demographic influence and population-based norms (the AGE study)
- (2007) Changsu Han et al. ARCHIVES OF GERONTOLOGY AND GERIATRICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started